Implementation of an HIV Pre-exposure Prophylaxis Strategy Into Abortion and Early Pregnancy Loss Care. (1st July 2022)

• Record Type: Journal Article
• Authors: Sonalkar, Sarita; McAllister, Arden; Kete, Corinne; Fishman, Jessica; Frarey, Alhambra; Short, William R.; Schreiber, Courtney A.; Teitelman, Anne
• Is Part Of: Journal of acquired immune deficiency syndromes. Volume 90(2022)Supplement 1
• Page Start: S129
• Page End: S133
• Publication Date: 2022-07-01
• Subjects: HIV -- PrEP -- induced abortion -- miscarriage -- implementation -- gynecology -- obstetrics; AIDS (Disease) -- Periodicals; Acquired Immunodeficiency Syndrome -- Periodicals; AIDS (Disease); Periodicals; 616.9792005
• DOI: 10.1097/QAI.0000000000002972
• Languages: English
• ISSNs: 1525-4135

Abstract

Abstract : Background: Family planning and abortion clinics routinely address sexual health. We sought to evaluate implementation outcomes of an HIV pre-exposure prophylaxis (PrEP) care strategy for patients seeking management of induced abortion and pregnancy loss. Setting: Single-center, urban, academic, hospital-based family planning service. Methods: We used a multifaceted implementation strategy directed toward family planning providers comprised of educational sessions, an electronic medical record-prompted verbal assessment of HIV risk, electronic medical record shortcuts for PrEP prescription, and support of a PrEP navigator. We assessed penetration of the intervention by calculating the penetration of a PrEP offer, measured as the proportion of encounters in which PrEP was offered to PrEP-eligible individuals. We evaluated feasibility, acceptability, and appropriateness of the intervention using belief elicitation interviews with providers. Results: From November 2018 to April 2019, the proportion of PrEP eligible patients who were offered PrEP, was 87.9% (29/33). Providers found the intervention acceptable and appropriate, but reported barriers including time constraints, and disappointment if patients did not adhere to PrEP. Providers liked that PrEP provision in abortion care settings felt innovative, and that they could contribute to HIV prevention. Conclusion: Family planning providers in an academic center found HIV risk assessment and PrEP provision to be feasible, acceptable, and appropriate. Further research should evaluate implementation outcomes of PrEP care strategies in additional abortion care contexts, including clinics offering reproductive health care outside of academia.